53 results
Page 2 of 3
8-K
EX-99.1
a8d3 xvhbq2
12 Nov 20
Motus GI Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
e4saz
28 Aug 20
Motus GI Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market
4:36pm
8-K
EX-10.2
qotwb9niyh gpwq
28 Aug 20
Motus GI Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market
4:36pm
8-K
yxt9e z0f
28 Aug 20
Motus GI Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market
4:36pm
PRE 14A
jipvr4rtkole 5tyc
22 Jun 20
Preliminary proxy
4:05pm
8-K
EX-99.1
d8n 5mkwo57
14 Nov 19
Motus GI Reports Third Quarter 2019 Financial Results and Provides Corporate Update
7:10am
8-K
EX-99.1
pnrl026p zjo75vpy1h6
9 Aug 19
Motus GI Reports Second Quarter 2019 Financial Results and Provides Corporate Update
7:30am
8-K
EX-99.1
y6jwv8k9bexai ed
11 Jun 19
Motus GI Receives FDA Clearance to Market Pure-Vu® GEN2
7:35am
8-K
EX-99.1
2gkva
10 May 19
Motus GI Reports First Quarter 2019 Financial Results and Provides Corporate Update
8:12am
DEF 14A
17jafqrzmb
3 May 19
Definitive proxy
7:34am